CARNITOR ORAL SOLUTION Rx
Generic Name and Formulations:
Levocarnitine 1g/10mL; cherry flavor.
Leadiant Biosciences, Inc.
Indications for CARNITOR ORAL SOLUTION:
Primary systemic or secondary carnitine deficiency.
Consume slowly in divided doses, preferably with meals; may mix in liquids. Initially 1g/day; titrate slowly; range 1–3g/day.
Consume slowly in divided doses, preferably with meals; may mix in liquids. Initially 50mg/kg/day; titrate slowly; range 50–100mg/kg (max 3g) per day.
Obtain baseline carnitine level; monitor blood chemistry, carnitine levels, vital signs, clinical condition. Seizure disorders. Renal insufficiency (oral forms). Pregnancy. Nursing mothers: not recommended.
Monitor INR with warfarin.
GI upset/pain, body odor, seizures; hypersensitivity reactions (discontinue if occur). Inj: also inj site reactions.
Tabs—90; Oral soln—118mL; Single-dose vials (5mL)—5
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients
- Changes in Renal Cell Carcinoma Pathologic Staging and Histologic Grading
- Nocturia, Overactive Bladder Improved With PTNS
- Many Americans Unaware of Promise of Personalized Medicine
- Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk
- VDRAs Do Not Lower Cardiovascular Event Risk in HD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)